Ubuwazi ukuthi isifo sikashukela sithinta izigidi zabantu emhlabeni wonke? Njengoba ukwanda kwalesi sifo kuqhubeka kwanda minyaka yonke, abacwaningi nodokotela basebenza ngokuzikhandla ukuze bathuthukise izindlela zokwelapha eziphumelelayo. Eminye yemithi enjalo yesifo sikashukela esithole ukunakwa yi-canagliflozin. Lo muthi unikeza indlela entsha yokulawula amazinga kashukela egazini futhi ubonise imiphumela emihle ezivivinyweni zomtholampilo.
Le bhulogi izohlola ukusetshenziswa kwezidakamizwa ze-canagliflozin, ukuphathwa kwazo okufanele, imiphumela engemihle engaba khona, nezinyathelo zokuphepha ezidingekayo.
Kuwumuthi osetshenziselwa ukwelapha isifo sikashukela sohlobo 2. Kungokwesigaba sezidakamizwa ezibizwa nge-sodium-glucose co-transporter 2 (SGLT2) inhibitors. Odokotela banquma i-canagliflozin ngokuhambisana nokudla nokuzivocavoca, futhi kwesinye isikhathi kuhlanganiswa neminye imithi, ukwehlisa ushukela wegazi ezigulini ezinesifo sikashukela sohlobo II.
Amaphilisi e-Canagliflozin anemisebenzi eminingana ebalulekile, njenge:
Iziguli kufanele zilandele le mihlahlandlela:
I-Canagliflozin, njengayo yonke imithi, ingase ibangele imiphumela engadingeki kanye nezinzuzo zayo ezihlosiwe. Le miphumela engemihle isukela kokuvamile kuya kwengavamile; amanye angase adinge usizo lwezokwelapha ngokushesha.
Iziguli ezithatha i-canagliflozin kufanele ziqaphele izinyathelo zokuphepha ezimbalwa ezibalulekile. Ukuhlolwa okuvamile nokubonisana ne-endocrinologist yakho kubalulekile ukuze kuqashwe imiphumela engadingeki.
I-Canagliflozin ihlose iphrotheni ethile ezinso ebizwa ngokuthi i-sodium-glucose co-transporter 2 (SGLT2). Le phrotheni ibamba iqhaza elibalulekile ekufakweni kabusha kweglucose. I-SGLT2 itholakala kuma-proximal tubules ezinso, lapho ngokuvamile imunca khona i-glucose ehlungiwe kulume lwe-renal tubular.
Lapho umuntu ethatha i-canagliflozin, ivimbela i-SGLT2 co-transporter. Lokhu kuvimbela kuholela emiphumeleni eminingi:
Umphumela walezi zenzo ukwehla kokugcwala kweglucose egazini, okuthuthukisa ukulawulwa kwe-glycemic kubantu abanesifo sikashukela sohlobo 2.
Eminye imithi ingaba nomthelela endleleni umzimba osebenza ngayo i-canagliflozin.
I-Canagliflozin iza ngethebhulethi futhi itholakala ngamandla angu-100mg kanye nama-300mg. Kubantu abadala abanohlobo 2 lwe-DM, umthamo wokuqala ngu-100mg othathwa ngomlomo kanye ngosuku ngaphambi kokudla kokuqala. Uma kubekezelelwa kahle futhi kudingeka ukulawula okwengeziwe kwe-glycemic, umthamo unganyuswa ube ngu-300mg ngosuku ezigulini ezine-eGFR ≥60 mL/min/1.73 m².
I-Canagliflozin ithinta ukuphathwa kwesifo sikashukela ngokunikeza indlela eyingqayizivele yokulawula ushukela wegazi. Isiza iziguli ezinesifo sikashukela sohlobo 2 ukwehlisa amazinga kashukela futhi kunezinzuzo ezengeziwe kulabo abanesifo senhliziyo nemithambo yegazi. Ikhono lomuthi lokunciphisa ubungozi bezehlakalo ezingathi sína zenhliziyo nemithambo yegazi kanye nesifo sezinso esifika esigabeni sokugcina kuwenza ube yimpahla enqolobaneni yokwelapha. Kodwa-ke, iziguli nodokotela kufanele balinganise lezi zinzuzo ngemiphumela engemihle engase ibe khona futhi bathathe izinyathelo zokuphepha ezidingekayo.
I-Canagliflozin isetshenziswa ngokuyinhloko ukuphatha nokulawula uhlobo 2 sikashukela i-mellitus. Yehlisa amazinga kashukela kubantu abadala uma isetshenziswa ngokuhambisana nokudla nokuzivocavoca. Ukwengeza, kunciphisa ingozi yezenzakalo ezinkulu zenhliziyo kubantu abanesifo sikashukela sohlobo 2 noma isifo senhliziyo esisungulwe. I-Canagliflozin futhi yehlisa ubungozi besifo sezinso sesigaba sokuphela kanye nokulaliswa esibhedlela ngenxa yokwehluleka kwenhliziyo kubantu abadala abanesifo sikashukela sohlobo 2 kanye ne-nephropathy yesifo sikashukela.
Abantu abadala abanesifo sikashukela sohlobo 2 abadinga ukulawulwa okungcono kwe-glycemic bangazuza ku-canagliflozin.
I-Canagliflozin iklanyelwe ukusetshenziswa nsuku zonke. Iziguli ngokuvamile zizithatha kanye ngosuku ngaphambi kokudla kwazo kokuqala. Kubalulekile ukuphuza imithi njengoba eyalelwa udokotela futhi ungashintshi umthamo ngaphandle kweseluleko sezokwelapha.
I-Canagliflozin ngokuvamile iphephile uma isetshenziswa njengokuyalelwa. Nokho, kungaba nemiphumela engemihle, okuhlanganisa ingozi eyengeziwe yokunqunywa kwezitho eziphansi kubantu abanesifo senhliziyo nemithambo yegazi. Eminye imiphumela engemihle engaba khona ihlanganisa izifo ze-mycotic zangasese, izifo zomgudu womchamo, kanye nemicimbi ehlobene nokuncipha kwevolumu.
I-Canagliflozin i-contraindicated ezigulini dialysis. Akunconyelwe ukuqaliswa ezigulini ezine-GFR elinganiselwe engaphansi kuka-30 mL/min/1.73 m². Abesifazane abakhulelwe, ikakhulukazi ku-trimester yesibili neyesithathu, kufanele bagweme ukusebenzisa i-canagliflozin.
I-Canagliflozin ibonise izinzuzo zempilo yezinso ezigulini ezithile. Kunganciphisa ubungozi besifo sezinso sesigaba sokugcina kanye nokusebenza kwezinso okubi kakhulu kubantu abadala abanesifo sikashukela sohlobo 2 kanye ne-nephropathy yesifo sikashukela.
I-Canagliflozin ivamise ukuthathwa ngaphambi kokudla kokuqala kosuku, imvamisa ekuseni. Odokotela ngokuvamile abatusi ukuyithatha ebusuku.
Isikhathi esihle sokuthatha i-canagliflozin ngaphambi kokudla kokuqala kosuku, okungcono kakhulu ekuseni. Lesi sikhathi sivumela umuthi ukuthi wehlise ukuhamba kweglucose ye-postprandial ngokubambezela ukumuncwa kweglucose emathunjini.